Related Experiment Video
Updated: Dec 16, 2025

11:35
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
58.5K
Time matters: Early-phase multiple sclerosis is accompanied by considerable impairments across multiple domains.
C Thrue1, M Riemenschneider1, L G Hvid1
1Exercise Biology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Summary
Early detection of multiple sclerosis (MS) impairments is crucial. Even within 5 years of diagnosis, patients show significant physical, cognitive, and patient-reported outcome deficits compared to healthy individuals.
Area of Science:
- Neurology
- Neuroimmunology
- Rehabilitation Medicine
Background:
- Multiple sclerosis (MS) causes disabling impairments across multiple domains.
- A
- time matters
- approach emphasizes early intervention in MS treatment.
- Optimizing MS care requires early detection of physical, cognitive, and patient-reported deficits.
Purpose of the Study:
- To review impairments in physical function, cognitive function, and patient-reported outcomes in early-stage MS (<=5 years post-diagnosis, including clinically isolated syndrome [CIS]).
- To compare these impairments against matched healthy controls.
Main Methods:
- Topical review of studies investigating early-stage MS/CIS.
- Comparison of functional and patient-reported outcomes between MS/CIS patients and healthy controls.
Main Results:
- Early-stage MS/CIS patients exhibit impairments ranging from 8%-34% across physical, cognitive, and patient-reported domains.
- Numerical effect sizes for these impairments range from small to large (0.35-2.85).
Conclusions:
- Significant multi-domain impairments are evident even in the early stages of MS.
- Early screening and targeted interventions are essential for managing MS.
- Preventive strategies to preserve or restore physical and cognitive reserve are critical.
Related Concept Videos
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Dissociative Identity Disorder
438
Dissociative Identity Disorder (DID), previously termed multiple personality disorder, is a complex psychological condition characterized by the presence of two or more distinct identities or personality states. Each identity exhibits unique patterns of behavior, voice, and mannerisms and may possess separate memories and emotional responses. The alternating control between identities can result in memory gaps and challenges in recalling daily activities, often exacerbating the individual's...
438

